{
  "eligibleTrials": [
    {
      "trialId": "NCT06577025",
      "studyTitle": "A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma",
      "eligibilityCriteriaMet": [
        "Diagnosis",
        "Stage",
        "Fitness",
        "Measurable Disease",
        "Performance Status",
        "Malignancy",
        "Neuropathy",
        "CNS Involvement",
        "Stroke/Seizure",
        "Plasma Cell Leukemia",
        "High-Risk Disease Features",
        "HIV Status"
      ]
    },
    {
      "trialId": "NCT06576323",
      "studyTitle": "An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)",
      "eligibilityCriteriaMet": [
        "Profession (Healthcare Provider)",
        "Relationship (Biological Mother)",
        "Postpartum Status (No more than 4 weeks postpartum)",
        "Mental Health (Active suicidal ideation, severe psychopathology)"
      ]
    },
    {
      "trialId": "NCT06576895",
      "studyTitle": "Nutrition Practice in Critically Ill Adults - an Observational Study",
      "eligibilityCriteriaMet": [
        "Age",
        "Admission Status",
        "Duration of Stay",
        "Discharge Status",
        "Care Type"
      ]
    },
    {
      "trialId": "NCT06576817",
      "studyTitle": "High-intensity Interval Circuit Training in People With Parkinson Disease",
      "eligibilityCriteriaMet": [
        "Diagnosis",
        "Disease Severity",
        "Mobility",
        "Medical Clearance",
        "Bone Health",
        "Injury",
        "Blood Pressure",
        "Diabetes",
        "Cardiovascular Health",
        "Medication Stability"
      ]
    }
  ]
}